• 정신신체의학
• /
• 제24권1호
• /
• pp.20-27
• /
• 2016

두통은 대부분의 사람들이 평생 한번씩은 경험하는 가장 흔한 신체증상이다. 심각한 상황을 야기하는 뇌종양과 같은 일부의 원인을 제외하고, 두통의 대부분은 편두통이나 긴장성 두통과 같은 일차성 두통으로 알려져 있다. 두통의 정확한 진단은 임상의들의 자세한 병력 청취와 신체 검사로부터 시작된다. 본 종설에서는 두통의 세부진단과 진단과정에 대해 고찰하고, 효과적인 약물치료 전략에 대해서 논의하고자 한다.

• Clinical and Experimental Pediatrics
• /
• 제58권2호
• /
• pp.60-63
• /
• 2015

Purpose: Many patients presenting with headache also complain of constipation; the relationship between these two symptoms has not been explored in detail. The aim of this study was to investigate the association between primary headache and constipation. Methods: This retrospective study included all children who attended the Inje University Sanggye Paik Hospital complaining of headache, and who had been followed up for at least 100 days. Patients were divided into 2 groups: group A, in whom the headache improved after treatment for constipation, and group B, in whom headache was not associated with constipation. Results: Of the 96 patients with primary headache, 24 (25.0%) also had constipation (group A). All 24 received treatment for constipation. Follow-up revealed an improvement in both headache and constipation in all patients. Group B contained the remaining 72 children. Comparison of groups A and B indicated a significant difference in sex ratio (P=0.009, chi-square test). Patients with probable tension-type headache were more likely to be in Group A (P=0.006, chi-square test). Conclusion: Resolution of constipation improves headache in many patients diagnosed with primary headache, especially those with probable tension-type headache. We suggest that either constipation plays a key role in triggering headache, or that both constipation and headache share a common pathophysiology.

• Journal of Oral Medicine and Pain
• /
• 제34권3호
• /
• pp.325-331
• /
• 2009

본 연구는 측두하악장애와 연관된 두통의 유병율을 평가하고 측두하악장애와 연관된 두통의 양상을 평가함으로써 두통과 측두하악장애와의 관계를 평가하기 위하여 시행되었다. 2008년 1월부터 2008년 6월까지 측두하악장애 관련 증상을 주소로 조선대학교 치과병원 구강내과에 내원한 환자 중 일차성 두통을 가지고 있는 환자 66명을 대상으로 하여, 측두하악장애, 두통에 관한 평가를 시행하였다. 연구결과는 다음과 같다. 1. 측두하악장애을 기준으로 분류하였을 경우, 측두하악관절 및 저작근이 동시에 이환된 경우가 66명 중 36명(54.5%)로 가장 많았다. 2. 두통을 기준으로 분류하였을 경우, 긴장성 두통이 66명중 59명(89.39%)로 가장 많았다. 3. 66명 중 36명(54.5%)이 측두하악장애와 연관된 두통을 호소하였다. 4. 측두하악장애와 연관된 두통을 호소한 36명 중 19명(52.78%)이 본래 존재한 일차성 두통과는 다른 양상이 측두하악장애와 연관되어 나타난다고 하였다. 즉 측두하악장애와 일차성 두통을 동시에 가지고 있는 경우, 측두하악장애와 연관된 두통이 상대적으로 흔하게 발생된다고 볼 수 있을 것이다. 또한 그 중 과반수 이상이 기존 두통양상과는 다른 증상을 호소하는 것으로 보아, 측두하악장애와 두통의 연관성을 연구하는데 있어 새로운 두통양상에 대한 연구가 추가적으로 이루어져야 할 것이다. 또한 측두하악장애와 두통과의 연관성을 평가하기 위해서는 보다 많은 모집단을 대상으로, 보다 세분화된 기준을 가지고 대조군을 설정하여 평가하는 것이 추후에 필요할 것으로 사료된다.

• 정신신체의학
• /
• 제7권2호
• /
• pp.263-273
• /
• 1999

두통은 인류의 가장 흔한 호소 중의 하나로 임상에서 흔히 보는 장애이다. 두통은 뇌막염, 뇌출혈, 또는 뇌종양과 같은 다른 질환의 증상일수 있으나, 또한 편두통이나 군발두통 등과 같은 질병 자체로 표현된다. 일차적으로 두통 장애의 역학이나 국제 두통학회의 진단기준을 이해하고 흔치 않으나 심각한 이차적인 두통장애와 감별에 관심을 둬야 한다. 환자가 일차 두통장애의 기준에 맞으면 신경학적 진단검사의 보충이 없어도 치료를 시작한다. 두통 유형, 표현 양상, 동통기간과 강도 등에 따라 진통소염제나 혼합진통제, 혈관작용의 항편두통 약물 또는 신경이완제나 corticosteroid등을 선택한다. 편두통의 빈도와 강도에 따라 예방치료가 보통 4~6개월간 조절한다. 긴장형 두통은 발작성과 만성두통으로 구분되나 치료적으로는 급성완화와 예방치료로 시도된다. 많은 만성매일두통 환자들이 진통제나 ergotamine을 과용하고 있으며 그들의 의존성과 내재된 갈등조절, 수면장애, 우울등으로 과용된 약물의 제한이 쉽지 않다. 치료의 첫단계는 약물을 끊고 조심스럽게 대치요법을 시행한다.

• Journal of Dental Anesthesia and Pain Medicine
• /
• 제21권5호
• /
• pp.413-429
• /
• 2021

Background: Migraine headaches are the second leading cause of disability worldwide and are responsible for significant morbidity, reduction in the quality of life, and loss of productivity on a global scale. The purpose of this systematic review and meta-analysis was to evaluate the efficacy of ketamine on migraines and other primary headache disorders compared to placebo and other active interventions, such as midazolam, metoclopramide/diphenhydramine, and prochlorperazine/diphenhydramine. Methods: An electronic search of databases published up to February 2021, including Medline via PubMed, EMBASE, Web of Science, and Cochrane Library, a hand search of the bibliographies of the included studies, as well as literature and systematic reviews found through the search was conducted to identify randomized controlled trials (RCTs) investigating ketamine in the treatment of migraine/headache disorders compared to the placebo. The authors assessed the risk of bias according to the Cochrane Handbook guidelines. Results: The initial search strategy yielded 398 unduplicated references, which were independently assessed by three review authors. After evaluation, this number was reduced to five RCTs (two unclear risk of bias and three high risk of bias). The total number of patients in all the studies was 193. Due to the high risk of bias, small sample size, heterogeneity of the outcomes reported, and heterogeneity of the comparison groups, the quality of the evidence was very low. One RCT reported that intranasal ketamine was superior to intranasal midazolam in improving the aura attack severity, but not duration, while another reported that intranasal ketamine was not superior to metoclopramide and diphenhydramine in reducing the headache severity. In one trial, subcutaneous ketamine was superior to saline in migraine severity reduction; however, intravenous (I.V.) ketamine was inferior to I.V. prochlorperazine and diphenhydramine in another study. Conclusion: Further double-blind controlled studies are needed to assess the efficacy of ketamine in treating acute and chronic refractory migraines and other primary headaches using intranasal and subcutaneous routes. These studies should include a long-term follow-up and different ketamine dosages in diagnosed patients following international standards for diagnosing headache/migraine.

• Journal of Korean Neurosurgical Society
• /
• 제48권1호
• /
• pp.82-84
• /
• 2010

The falcine sinus is an abnormal anatomic structure located in the falx cerebri that is closed after birth and is rarely observed. We describe two cases of persistent falcine sinus. A 60-year-old woman presented with headache. An 11-year-old girl presented with intermittent headache and a palpable scalp mass in the middle of the high parietal area. The straight sinuses were absent in both patients. In both patients, drainage of the galenic system took place through a sinus within the falx, also known as a falcine sinus. Suspicious dysplastic tentorium cerebelli was observed in one patient. It can be concluded that a mesenchymal disorder can be the primary cause for a persistent falcine sinus.

• 동의신경정신과학회지
• /
• 제9권2호
• /
• pp.161-169
• /
• 1998

A clinical analysis was carried out for 19 patients who was treated in Dept. of Neuropsychiatry of Taejon Oriental Medicine Hospital from I aug. 1997 to 31 Jul. 1998 and was ruled out as anxiety disorder. The results were summarized as follows. 1. In the distribution of the sex, ratio between female and male was 1:2.8, distribution of the age was even each age, and the primary motive of the onset were psychological trauma, question of money, discord of a household. 2. As for the duration in disease, the duration from a week to a month had a majority of all, and the most duration of the addmission-treatment was a week. 3. The most common symptom were palpitation ·anxiety, headache·dizziness, chest discomfort, the cases of generalized anxiety disorder and atypical anxiety disorder was a large number. 4. In the aromatherapy of absorptive method, the sort of many used essential oil were Lavenda and Rosewood, in the massage, that were Peppermint and Rosemary. 5. The most used recipes were BUNSIMKIYEM(分心氣飮) HACHULBOSIMTANG(夏朮補心湯), CHUNGGANSOYOSAN(淸肝逍遙散), BANHABAEKCHUCHUNMATANG(半夏白朮天麻湯), CUIBIONDAMTANG(歸脾溫膽湯) etc. 6. In the judgement of efficacy, 9 cases showed good efficacy, 9 cases showed no change, 1 case showed excellent efficacy.

• Journal of Oral Medicine and Pain
• /
• 제31권4호
• /
• pp.355-364
• /
• 2006

두통은 매우 흔한 질환 중 하나로 개인적으로나 사회적으로 미치는 영향이 크다. 측두하악장애는 측두하악관절과 주위 근육의 통증과 기능장애를 통칭하는 용어로 전 인구의 70%에서 하나 이상의 관련된 증상을 호소할만큼 흔한 질환이다. 두통과 측두하악장애의 연관성에 대한 다양한 연구가 이루어지고 있으며, 몇몇 저자들은 일부 두통이 측두하악장애와 관련이 있는 것으로 보고하였다. 본 연구는 구강내과, 턱관절 및 안면통증 클리닉에 내원한 구강안면통증 환자의 두통 양상을 분석해 보았다. 전체 530명의 환자 중 긴장형 두통이 292명(48.5%)으로 가장 높은 비율을 차지하였고, 무전조성 편두통이 90명(15.0%), 개연적 편두통이 64명(10.6%), 유전조성 편두통이 43명(7.1%), 개연적 긴장형 두통이 29명(4.8%), 기타 일차성 두통이 11명(1.8%)으로 나타나 긴장형 두통 군의 비율이 상당히 높게 나타났는데 이는 구강안면통증 환자들이 대부분 근막동통 등 두개안면 근육의 통증을 동반하기 때문인 것으로 추측할 수 있다. 성별에 따른 분류에서 편두통은 남성(25.3%)보다 여성(35.8%)에서 높은 발생율을 나타냈다. 연령에 따른 분류에서는 20대와 30대에서 편두통 군의 비율이 각각 42.2%, 40.0%로 높게 나타났고, 연령이 증가할수록 감소하다가 50대에서 다시 증가추세를 나타내는 양상을 보여 기존의 연구들과 일치하는 결과를 보였다. 이전에 두통 때문에 진료를 받았던 경험이 있는 환자는 139명으로 26.2%에 불과했으며, 자신의 진단명을 알고 있는 경우는 46명으로 전체 환자의 8.7%밖에 되지 않았다. 이와 같이 환자들이 두통으로 인해 병원에서 진단 및 치료를 받는 경우는 드문 실정이지만, 구강안면통증과 두통은 동반되어 나타나는 경우가 많기 때문에 구강안면통증을 주소로 내원한 환자에서 두통이 동반된 경우 이에 대한 정확한 진단과 치료가 필요하리라 사료된다. 또한 측두하악장애는 두통의 유발 및 악화요인이 될 수 있으므로 두통 환자의 진단 및 치료시 측두하악장애의 증상에 대한 평가 및 적절한 관리가 중요하리라 사료되며, 향후 측두하악장애의 원인요소가 두통에 미치는 영향과 측두하악장애의 치료에 따른 두통의 변화 양상을 연구하는 등 보다 체계적이고 다양한 접근이 필요할 것으로 생각되는 바이다.

• 대한두개안면성형외과학회지
• /
• 제24권5호
• /
• pp.244-249
• /
• 2023

Fibrous dysplasia (FD) is a rare skeletal disorder characterized by abnormal fibro-osseous connective tissue replacing normal bone. Despite its benign behavior, craniofacial FD can cause morphological disfigurement, headache, and even blindness as a result of the produced mass effect. Surgical resection is recommended when the patient shows apparent clinical symptoms or aggravating facial asymmetry. Postoperative complications have been reported, such as hematoma, surgical site infection, abscess formation, resorption of the bone graft used for reconstruction, and recurrence. An aneurysmal bone cyst (ABC) is a rare benign bony lesion that can occur secondary to preexisting bone tumor. Secondary ABCs in craniofacial FD are extremely rare in the literature, accounting for less than 30, all of which are either case reports or series. We report an extremely rare case of symptomatic secondary ABC arising from craniofacial FD that had been misdiagnosed with abscess formation or recurrence and was surgically removed. Notably, 17 years elapsed between the primary surgery and the complication of secondary ABC. The patient underwent total removal of secondary ABC. After surgery, symptoms were relieved, with no recurrence observed during a 6-month follow-up.

• 대한약침학회지
• /
• 제27권3호
• /
• pp.177-189
• /
• 2024

Objectives: Cupping therapy is a widely used complementary medicine for the treatment of migraine headaches globally. However, conflicting evidence exists on its effectiveness. To evaluate the safety and efficacy of cupping therapy in treating migraine headache disorder. Methods: Seven databases were systematically searched: PubMed/MEDLINE, Clinicaltrials.gov, Cochrane CENTRAL, ScienceDirect, ProQuest, SinoMed, and the National Science and Technology Library. The primary endpoints are the treatment success and the pain intensity reduction. The secondary endpoints were adverse events (AEs) risk and improvement in quality of life (QoL), which was based on the Migraine Disability Scale (MIDAS). Subgroup analyses were performed based on the cupping techniques (wet and dry cupping) and adjunctive complementary treatments (i.e. acupuncture and/or collateral pricking). Results: Eighteen trials out of 348 records were included, pooling 1,446 participants (n = 797 received cupping therapy). Treatment success was significantly higher among those with cupping therapy (risk ratio [RR] [95% CI] = 1.83 [1.52-2.21]); with significant improvement observed only with wet cupping (RR [95% CI] = 1.88 [1.53-2.30]). The adjunctive complementary therapy did not achieve a greater amplitude of treatment success compared to cupping therapy alone. Furthermore, cupping therapy showed significant pain reduction compared to baseline (standardized mean difference [SMD] [95% CI] = 0.55 [0.39-0.70]) and achieved fewer risks of AEs (RR [95% CI] = 1.88 [1.53-2.30]). However, cupping did not improve the overall QoL (MIDAS SMD [95% CI] = -0.79 [-3.55-1.98]). Conclusion: Cupping therapy was an effective complementary modality to treat migraine headaches. However, it did not demonstrate improvement in QoL (PROSPERO: CRD42024514509).